This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: The State University of New York. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Tymish Y Ohulchansky: Innovator in Photodynamic Therapy
Introduction
Tymish Y Ohulchansky is a notable inventor based in Kenmore, NY (US). He has made significant contributions to the field of photodynamic therapy through his innovative research and development of ceramic-based nanoparticles.
Latest Patents
Ohulchansky holds a patent for "Ceramic based nanoparticles for entrapping therapeutic agents for photodynamic therapy and method of using same." This invention provides methods and compositions for photodynamic therapy, utilizing ceramic nanoparticles to entrap photosensitive drugs or dyes. The ceramic nanoparticles are created through a micellar composition of the dye, followed by the addition of ceramic material and precipitation via alkaline hydrolysis. The resulting nanoparticles are spherical, highly monodispersed, and stable in aqueous systems. When irradiated with light of a suitable wavelength, these nanoparticles generate singlet oxygen, which can diffuse through the ceramic matrix, making them effective drug carriers for photodynamic therapy.
Career Highlights
Throughout his career, Tymish Y Ohulchansky has worked with esteemed institutions such as the State University of New York and Health Research, Inc. His work has focused on advancing therapeutic techniques and improving patient outcomes through innovative drug delivery systems.
Collaborations
Ohulchansky has collaborated with notable colleagues, including Paras Nath Prasad and Indrajit Roy, who have contributed to his research endeavors.
Conclusion
Tymish Y Ohulchansky's work in the development of ceramic-based nanoparticles represents a significant advancement in the field of photodynamic therapy. His innovative approach to drug delivery systems has the potential to enhance treatment efficacy and improve patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
